HealthcareServices

Point Of Care Infectious Disease Testing Market Insights Report: Opportunities and Drivers 2030

March 5, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the point of care infectious disease testing market from 2026–2035 with trusted insights from The Business Research Company

By how much is the Point Of Care Infectious Disease Testing Market expected to grow between 2026 and 2030?

The point of care infectious disease testing market has witnessed rapid growth in recent years. It is forecast to grow from $4.78 billion in 2025 to $5.44 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 13.7%. This historical growth can be linked to factors such as the rising incidence of infectious diseases, an increased need for rapid diagnostics, the expansion of decentralized healthcare delivery, the availability of lateral flow testing technologies, and the growing utilization of rapid screening within hospitals.

The point of care infectious disease testing market is anticipated to experience substantial expansion over the next few years, projected to reach $9.02 billion in 2030 with a compound annual growth rate (CAGR) of 13.5%. This growth during the forecast period is attributable to the increasing embrace of self-testing solutions, the broadening scope of molecular point-of-care diagnostics, escalating investments in digital health integration, a heightened focus on outbreak preparedness, and the rising demand for low-cost rapid tests. Prominent trends for the upcoming period include the growing adoption of rapid molecular point-of-care tests, an increasing demand for home-based infectious disease testing, the expanding use of multiplex diagnostic kits, the proliferation of portable diagnostic instruments, and an intensified focus on early disease detection.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24382&type=smp

Which Drivers Are Influencing Market Acceleration In The Point Of Care Infectious Disease Testing Market?

The anticipated expansion of the point of care infectious disease testing market is driven by the increasing prevalence of contagious diseases. Such diseases are defined as illnesses transferable among individuals via direct contact, airborne particles, or alternative transmission methods. The primary reason for this increase in contagious disease cases is heightened human mobility, which enables infectious agents to spread more rapidly and extensively across regions and nations. Point of care infectious disease testing plays a crucial role by expediting the detection and diagnosis of these diseases, thereby facilitating prompt treatment and mitigating community transmission risks. As an illustration, in June 2024, data from the UK Health Security Agency, a UK-based government agency, revealed that from week 40 of 2022 to week 15 of 2023, 108 NHS trusts in England reported 1,681 critical care admissions attributed to confirmed influenza. This figure stands in stark contrast to the prior flu season, which saw only 182 admissions across 114 trusts, a number that subsequently rose to 316 by week 39 of 2022. Consequently, the escalating number of contagious diseases is a significant factor propelling the expansion of the point of care infectious disease testing market.

What Segments Are Identified Within The Structure Of The Point Of Care Infectious Disease Testing Market?

The point of care infectious disease testing market covered in this report is segmented –

1) By Product: Kits And Reagents, Instruments

2) By Technology: Lateral Flow Immunoassay, Agglutination Test, Flow-through Test Or Immunoconcentration Assay, Molecular Diagnostics, Other Technologies

3) By Disease: Human Immunodeficiency Virus Point-of-Care Testing, Clostridium Difficile Point-of-Care Testing, Hepatitis B Virus Point-of-Care Testing, Pneumonia or Streptococcus Associated Infections, Respiratory Syncytial Virus Point-of-Care Testing, Human Papillomavirus Point-of-Care Testing, Influenza Or Flu Point-of-Care Testing, Other Diseases

4) By End Use: Hospitals, Diagnostic Centers, Research and Academic Institutes, Homecare Settings, Other End Users

Subsegments:

1) By Kits And Reagents: Test Kits, Reagents

2) By Instruments: Portable Devices, Automated Analyzers

What Industry Trends Are Transforming The Point Of Care Infectious Disease Testing Market?

Leading firms within the point-of-care infectious disease testing market are prioritizing the incorporation of cutting-edge innovations, such as proprietary microfluidic technology, aiming to boost precision in testing, shorten result delivery times, and better patient health outcomes. This specialized microfluidic technology involves advanced systems capable of handling minute fluid volumes at a microscopic level, facilitating quick, accurate, and economical analysis. Its utility in point of care (POC) infectious disease testing stems from its capacity for swift, on-site pathogen identification, combining sample gathering, analysis, and result generation, thus accelerating diagnostics and broadening access without relying on central laboratory facilities. For instance, in June 2023, Sysmex Corporation, a Japan-based diagnostics company, launched the PA-100 AST System in Europe, which represents the globe’s inaugural point-of-care testing product designed for direct antimicrobial susceptibility detection. Leveraging sophisticated microfluidic techniques, this system facilitates quick identification of bacterial pathogens and assesses the efficacy of antimicrobials, thereby substantially cutting down on processing duration when juxtaposed with traditional approaches. The setup includes a small, desktop-sized analyzer along with disposable sample cartridges, rendering it ideal for use in close-to-patient environments like primary care clinics. Intended to aid in quicker and more precise decisions regarding antimicrobial therapy, this system supports worldwide initiatives to counteract antimicrobial resistance through enhanced diagnostic effectiveness.

Which Major Firms Are Strengthening Their Position In The Point Of Care Infectious Disease Testing Market?

Major companies operating in the point of care infectious disease testing market are Cardinal Health, F Hoffmann La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Becton Dickinson and Company, bioMérieux Société Anonyme, QuidelOrtho Corporation, Bio Rad Laboratories Inc., DiaSorin Società per Azioni, Danaher Corporation, Cue Health Inc., Nova Biomedical Corporation, Seegene Incorporated, Biosynex Société Anonyme, Trivitron Healthcare Private Limited, EKF Diagnostics Holdings plc, Trinity Biotech Public Limited Company, bioLytical Laboratories Inc., Cepheid Inc., LumiraDx UK Ltd., Meridian Bioscience Inc., GenBody Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/point-of-care-infectious-disease-testing-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Point Of Care Infectious Disease Testing Market?

North America was the largest region in the point of care infectious disease testing market in 2025. Asia-Pacific is expected to be the Fastest-Growing region in the forecast period. The regions covered in the point of care infectious disease testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Point Of Care Infectious Disease Testing Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24382&type=smp

Browse Through More Reports Similar to the Global Point Of Care Infectious Disease Testing Market 2026, By The Business Research Company

Point Of Care Poc Coagulation Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/point-of-care-poc-coagulation-testing-global-market-report

Point Of Care Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/point-of-care-diagnostics-global-market-report

Hospital Acquired Infections Testing Kits Market Report 2026

https://www.thebusinessresearchcompany.com/report/hospital-acquired-infections-testing-kits-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795